ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.124,97
1,20%
Dow Jones
38.662,91
1,14%
Euro vs US Dollar
1,07655
0,33%
Bitcoin
61.959,65
4,80%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Biodesix Inc (BDSX)

  7. Biodesix Inc (BDSX) News

BDSX Biodesix Inc

1,32
0,01 (0,76%)
Zuletzt aktualisiert: 18:20:23
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Biodesix Inc BDSX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,01 0,76% 1,32 18:20:23
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,33 1,31 1,34 1,31
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.4.202412:00BWBiodesix to Report First Quarter 2024 Financial Results on..
09.4.202423:00BWBiodesix to Present New Data on Liquid Biopsy Technologies..
05.4.202413:17BWBiodesix Announces Pricing of Oversubscribed and Upsized..
25.3.202411:00BWBiodesix Announces New Master Collaborative Research..
01.3.202412:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01.3.202412:05EDGAR2Form 8-K - Current report
01.3.202412:00BWBiodesix Announces Fourth Quarter and Fiscal Year 2023..
01.3.202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202412:00BWBiodesix to Participate in the TD Cowen 44th Annual Health..
16.2.202412:00BWBiodesix to Report Fourth Quarter and Full Year 2023..
13.2.202403:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202403:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.2.202401:06EDGAR2Form 144 - Report of proposed sale of securities
10.2.202401:05EDGAR2Form 144 - Report of proposed sale of securities
10.2.202401:05EDGAR2Form 144 - Report of proposed sale of securities
10.2.202401:04EDGAR2Form 144 - Report of proposed sale of securities
02.2.202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
03.1.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202315:19EDGAR2Form 8-K - Current report
14.11.202312:00BWBiodesix Enhances Access to Nodify Lung® Testing with Launch..
13.11.202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202312:00BWBiodesix to Participate in Two Upcoming Investor Conferences..
07.11.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:02EDGAR2Form 8-K - Current report
07.11.202322:01BW Biodesix Announces Third Quarter 2023 Results and..
24.10.202312:00BWBiodesix to Report Third Quarter 2023 Financial Results on..
03.10.202312:00BWBiodesix to Present New Data on Nodify Lung® Testing at..
07.9.202312:00BWBiodesix Announces Two Presentations on Lung Cancer..
05.9.202312:00BWBiodesix to Participate in Two Upcoming Investor Conferences..
22.8.202312:00BWBiodesix Announces Presentation of New Nodify XL2® Data at..
11.8.202301:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202301:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202301:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202301:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202301:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202322:30EDGAR2Form 144 - Report of proposed sale of securities
07.8.202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
BDSX
Biodesix
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten